AS-OCT Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification

Anterior Segment Optical Coherence Tomography Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification and YAG Laser Iridotomy, Comparative Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05332665

Enrollment

Registered

2022-04-18

Start date

2022-01-11

Completion date

2022-12-31

Last updated

2022-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Angle-Closure

Brief summary

Evaluation of the effect of phacoemulsification and YAG Laser peripheral iridotomy on the anterior chamber angle anatomic parameters in PACG eyes, using anterior segment optical coherence tomography (SS ASOCT) device

Detailed description

The recent treatment of ACG is phacoemulsification in patients of acute attack with YAG laser iridotomy in the other eye. The AS-OCT will be used for evaluation of the angle of the anterior chamber parameters in both eyes after phacoemulsification and YAG laser peripheral iridotomy. Follow up of AS-OCT will be done 1,3,6 months after surgery and we will compare results in each eye and between both eyes. .

Interventions

DEVICEAS-OCT

Anterior segment optical coherence tomography (AS OCT) is an imaging device that can acquire an anterior segment image using a noncontact method with the patient in a sitting position. This device provides reproducible and quantitative measurements of the AC angle and other anterior segment parameters.

PROCEDUREYAG laser PI

medical procedure which uses a laser device to create a hole in the iris, thereby allowing aqueous humor to traverse directly from the posterior to the anterior chamber and, consequently, relieve a pupillary block

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to 60 Years

Healthy volunteers

Inclusion criteria

* patients with acute attack of angle closure glaucoma in one eye. * Patients fit for phacoemulsification

Exclusion criteria

* 1- Patients with history of any intraocular surgery. 2- Patients with history of refractive surgery. 3- Patients with diabetic retinal vasculopathy or retinal detachment. 4- Patients with chronic angle closure glaucoma, open angle glaucoma or 2ry glaucoma

Design outcomes

Primary

Measure	Time frame	Description
IOP	up to 6 months	mmhg

Secondary

Measure	Time frame	Description
Corneal endothelial count	up to 6 months	CD per mm2

Countries

Egypt

Contacts

Primary Contactmohamed Salah

drmsalah1982@yahoo.com01003321802

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026